(fold of TGF-β1 response)

Slides:

Advertisements

Similar presentations

A B Supplementary Figure 1: A, TRAIL-induced apoptosis in melanoma cells and melanocytes. Cells were treated with TRAIL (200ng/ml) for 24 hours before.

Advertisements

BEL7402Huh7 C Tet Rapa C Tet Rapa LC3-II LC3-I GAPDH Figure S1 Detecting Tetrandrine-induced autophagy in Huh7 and BEL7402 cell lines. Rapamycin treatment.

PP1 and PP2A inhibitors rescue α-SMA expression and Akt phosphorylation from the inhibitory effects of TSA. After serum starvation, NHLFs were pretreated.

Figure 3. CSE increases the production of IL-8 in A549 cells

Supplementary Figure S4

Figure 3. Synergistic effects of the combination of trabectedin and olaparib on poly(ADP-ribosyl)ation and DNA damage in four different breast cancer cell.

B A P-AXL P-AXL AXL AXL P-MET P-MET MET MET P-Akt-473 P-Akt-473 AKT

Figure 3. Elevation of p53 and its acetylation after treatment with FK866 and nicotinamide adenine dinucleotide (NAD+). Cells were treated for 72 hours.

From: β-Catenin/CBP–Dependent Signaling Regulates TGF-β–Induced Epithelial to Mesenchymal Transition of Lens Epithelial Cells Invest. Ophthalmol. Vis.

Supplementary Figure 1 Lapatinib nM mM pEGFR MDA-MB231 EGFR pEGFR

A B C MDA-MB-231 OHT: h FOXM1 PLK CDC25b ERα Tubulin

Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-κB by Lara F. Costa, Mercedes.

TGF-β1 induces ILK activity in renal tubular epithelial cells.

Inhibition of ILK restores epithelial ZO-1 and E-cadherin and inhibits fibronectin and Snail1 expression after TGF-β1 treatment. Inhibition of ILK restores.

Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.

Rapamycin is an effective inhibitor of human renal cancer metastasis1

Volume 78, Issue 4, Pages (August 2010)

2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized.

Volume 18, Issue 11, Pages (November 2011)

Volume 28, Issue 3, Pages (September 2015)

Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach Ajaya Kumar Reka, PhD, Rork Kuick, MS, Himabindu.

Insulin-Like Growth Factor-I Enhances Transforming Growth Factor-β-Induced Extracellular Matrix Protein Production Through the P38/Activating Transcription.

Figure S1 Nil + CK Nil CK C BIM BCLXL Pro-caspase 3 Cleaved caspase 3

Volume 16, Issue 4, Pages (October 2009)

Short-chain fatty acids induce cell cycle inhibitors in colonocytes

Volume 120, Issue 6, Pages (March 2005)

Synergistic effect of S63845 with lapatinib, trastuzumab, or docetaxel

Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation A.

Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C

relative to untreated vector

PDGFRα GBM primary cultures demonstrate titratable and temporal DOX-inducible expression of hPDGF-A and receptor activation. PDGFRα GBM primary cultures.

Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor β-3 Doina S. Joseph, M.S., Minnie Malik, Ph.D., Sahadat.

Transforming growth factor (TGF)-β1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation.

LXRα Enhances Lipid Synthesis in SZ95 Sebocytes

Immunosuppression-induced bronchial epithelial–mesenchymal transition: A potential contributor to obliterative bronchiolitis Valerie M. Felton, Landon.

Volume 54, Issue 4, Pages (October 1998)

Volume 20, Issue 5, Pages (December 2005)

1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression Yingjian Li, Bradley C.

Volume 62, Issue 3, Pages (September 2002)

Volume 117, Issue 5, Pages (November 1999)

Implication of prostaglandin E2 in TNF-α-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs K. Fushimi,

Kellie J. White, Vincent J. Maffei, Marvin Newton-West, Robert A

Volume 138, Issue 4, Pages (April 2010)

Molecular mechanism of STING-mediated inhibition of the mTORC1 pathway

Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells Gur P. Kaushal, Varsha Kaushal, Ph.D., Xiaoman.

Volume 116, Issue 6, Pages (June 1999)

Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy

Nestin expression in the kidney with an obstructed ureter

Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37 Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.

Leto et al., Supplementary Figure S3

Volume 83, Issue 5, Pages (November 2002)

Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa

HCT-15 HT-29 * Figure S1. Oxaliplatin treatment increases CD44high subpopulations in both HCT-15 and HT-29 cells. Flow.

Volume 70, Issue 5, Pages (September 2006)

Pharmacologic inhibition of eIF5A hypusination sensitizes KRas-driven tumor cells to MEK and KRas inhibition. Pharmacologic inhibition of eIF5A hypusination.

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB

Keratinocytes Inhibit Expression of Connective Tissue Growth Factor in Fibroblasts In Vitro by an Interleukin-1α-Dependent Mechanism Daniel Nowinski,

Fig. 3. Relative expression levels of ASNS to α-tubulin were dramatically increased when treating human cells with nocodazole and ASNase. Relative expression.

Leptin and amylin signaling.

Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.

(fold of TGF-β1 response)

Inhibition of BCR activation by orthogonal inhibitors of SYK-AQL.

Raghvendra Singh, Stelios T Andreadis Molecular Therapy

Modification of the β-tubulin C-terminal tail does not affect the partitioning of tubulin between the soluble and polymerized fractions in response to.

Figure 1. Effect of a peroxynitrite scavenger on high glucose-induced apoptosis in LLC-PK1 cells. Subconfluent monolayers of LLC-PK1 cells in 6-well tissue.

TGF-β1 modulates extracellular matrix–mediated MT1-MMP expression.

HDACI treatment leads to down-regulation of AR and neuroendocrine transdifferentiation of LNCaP or LAPC4 cells. HDACI treatment leads to down-regulation.

FGFR1 is dominantly expressed in mesenchymal-like KRAS-mutant lung cancer cell lines. FGFR1 is dominantly expressed in mesenchymal-like KRAS-mutant lung.

Combined inhibition of coamplified RTKs is required for response.

TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.

Presentation transcript:

(fold of TGF-β1 response) (A) (D) TGF-β1 PFD (mM) - 3 5 + αSMA β-tubulin Rapa (nM) 50 100 CPA (μM) 36 180 FK (μM) 10 HC (μM) 1 AZA (μM) 18 (B) (E) (C) (F) (G) 1.0 (fold of TGF-β1 response) αSMA 0.5 - ＋ TGF-β1 + Inh (µM) FK (10) CPA (180) AZA (18) Rapa (0.1) HC (10) PFD (5000) Changes in αSMA levels by immunosuppressants and pirfenidone in HFL-1 cells with and without TGF-β1. HFL-1 cells were treated with 10 ng/mL TGF-β1 in the presence of the indicated concentrations of FK506 (A), cyclophosphamide (B, CPA), azathiopurine (C, AZA), rapamycin (D, Rapa), hydrocortisone (E, HC), and pirfenidone (F, PFD) for 48 h. Cell lysates were subjected to Western blotting for αSMA and β-tubulin. (G) Quantitative data for αSMA levels at the indicated concentration of each drug are expressed as fold changes from the TGF-β1-alone response. Data are means ± S.E. from three to five individual experiments. Figure S1